Polymer-drug conjugate for osteoarthritis

Paula Hammond & Alan Grodzinsky with Brandon Johnston

Osteoarthritis affects 30 million Americans, however, there exists no drug that can slow disease progression. This project is developing a nanomaterial capable of targeted, sustained delivery of drugs to cartilage.  By improving drug delivery to cartilage, the project aims to improve drug efficacy and create an osteoarthritis drug that can treat the underlying cause of the disease.

See Brandon Johnston present their project at IdeaStream 2020.